Publication Name	World Journal of Diabetes
Manuscript ID	88821
Country	China

Received	2023-11-06 09:13
Peer-Review Started	2023-11-06 09:13
To Make the First Decision
Return for Revision	2023-11-16 01:59
Revised	2023-11-17 11:56
Second Decision	2023-12-11 06:28
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-12-18 08:56
Articles in Press	2023-12-18 08:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-29 17:15
Publish the Manuscript Online	2024-02-04 10:57

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Research & Experimental Medicine
Manuscript Type	Observational Study
Article Title	Serum tumor markers expression (CA 199, CA 242, and CEA) and its clinical implications in type 2 diabetes mellitus
Manuscript Source	Unsolicited Manuscript
All Author List	Mei Meng and Li-Li Shi
ORCID	Author(s) ORCID Number Li-Li Shi http://orcid.org/0009-0005-3739-0211
Funding Agency and Grant Number
Corresponding Author	Li-Li Shi, MD, PhD, Chief Doctor, Department of Cadre Ward, The First Affiliated Hospital of Harbin Medical University, No. 23 Postal Street, Nangang District, Harbin 150001, Heilongjiang Province, China. shi_lili1983@163.com
Key Words	Type 2 diabetes mellitus; Carcinoembryonic antigen; Cancer antigen 199; Cancer antigen 242; Glycosylated hemoglobin
Core Tip	Levels of serum cancer antigen (CA)199, carcinoembryonic antigen (CEA), and CA242 demonstrated close association with glycosylated hemoglobin (HbA1c) and fasting blood glucose levels in patients with type 2 diabetes mellitus. Furthermore, CA199 and CEA levels had good predictive power for HbA1c levels. These findings suggest the need for monitoring tumor marker changes in those with poorly controlled blood sugar levels.
Publish Date	2024-02-04 10:57
Citation	Meng M, Shi LL. Serum tumor markers expression (CA 199, CA 242, and CEA) and its clinical implications in type 2 diabetes mellitus. World J Diabetes 2024; 15(2): 232-239
URL	https://www.wjgnet.com/1948-9358/full/v15/i2/232.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i2.232

Full Article (PDF)	WJD-15-232-with-cover.pdf
Full Article (Word)	WJD-15-232.docx
STROBE Statement	88821-STROBE statement.pdf
Manuscript File	88821_Auto_Edited-YJP.docx
Answering Reviewers	88821-Answering reviewers.pdf
Audio Core Tip	88821-Audio core tip.aac
Biostatistics Review Certificate	88821-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	88821-Conflict-of-interest statement.pdf
Copyright License Agreement	88821-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	88821-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	88821-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	88821-Language certificate.pdf
Peer-review Report	88821-Peer-review(s).pdf
Scientific Misconduct Check	88821-Bing-Lin C-2.png
Scientific Editor Work List	88821-Scientific editor work list.pdf
CrossCheck Report	88821-CrossCheck.png
CrossCheck Report	88821-CrossCheck report.pdf